Office of Development

$2 million grant expands minority access to cancer trials

Dr. William “Rusty” Robinson, head of gynecologic oncology at Tulane, will lead the $2 million grant from the National Cancer Institute. 

Dr. William “Rusty” Robinson, head of gynecologic oncology at Tulane, says the $2 million grant from the National Cancer Institute will help overcome historic barriers that have prevented minority accruals to clinical research trials in the past. (Photo by Paula Burch-Celentano)

October 4, 2012

Keith Brannon
kbrannon@tulane.edu 

Tulane University School of Medicine will use a $2 million grant from the National Cancer Institute to increase the number of minority patients enrolled in clinical trials for new cancer therapies, led by Dr. William “Rusty” Robinson, head of gynecologic oncology at Tulane.

The Minority-Based Community Clinical Oncology Program (MB-CCOP) grant is part of a national effort to support community-based cancer trials that bring in racial and ethnic groups typically underrepresented in clinical research. The Tulane MB-CCOP is one of 17 across the country. More...